Remote gynecology systems deployed to save African women


Illumigyne Gynescope, a one-of-a-kind, fully remote gynecological imaging platform, will be distributed across Africa to improve cervical cancer early diagnosis and detection rates.

According to the World Health Organization, of the 20 countries with the highest prevalence rates in the world, 19 are in Africa. Cervical cancer is also the second most common and deadly cancer in women in sub-Saharan Africa, with more women dying each year from cervical cancer than during childbirth.

However, when diagnosed early, cervical cancer is one of the most treatable forms of cancer. This is why Illumigyn and Peramare Enterprises signed a distribution agreement for 20,000 units of Gynescope.

“This partnership has a very important goal: to ensure the early detection of cervical cancer in women in Africa,” said Ran Poliakine, founder of Illumigyn.

“We created Illumigyn to democratize women’s health care and bring advanced gynecological care to women around the world, and we are proud to lead change across Africa,” he added.

The system performs high resolution imaging of the cervix, vagina and external genitalia. The images are uploaded to Illumigyn’s secure cloud, to be used for remote diagnostics, ongoing medical monitoring and additional consultations.

Since the system can be used by any trained caregiver, including nurses and midwives, it allows women to be screened and diagnosed even in remote locations without access to doctors.

The deal was made possible by credit support from Afreximbank, a pan-African multilateral trade finance institution.

“Cervical cancer is one of the killers of our women,” said Oluranti Doherty, Afreximbank’s export development director.

“Any attempt at early detection and prevention is a very welcome step. In my mind, Illumigyn’s solution brings great relief, which will have many health and socio-economic benefits for women.

In September, Illumigyn signed a memorandum of understanding to bring 2,500 gynescopes to the Gulf States.


About Author

Comments are closed.